SMAD3 and hepatocellular carcinoma: These results indicate that MUC1 activates JNK and enhances cell proliferation by shifting Smad3 signaling from a tumor-suppressive pSmad3C/p21WAF1 pathway to an oncogenic pSmad3L/c-Myc pathway in HCC cells.